ArticleAsian Pacific journal of cancer prevention : APJCP2025

Antiproliferative Potential of Linagliptin-Rivaroxaban Mixture in Cervical Cancer: Mechanistic Insights into Targeting Mutant MAPK, RAS kinase Signal Protein.

Buthaina Jasim Yousif et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.